Antiretroviral drugs in development. A report from HIV DART 2008: frontiers in drug development for antiretroviral therapies
Zelalem Temesgen
Abstract
Zelalem Temesgen
Abstract
HIV DART 2008, Frontiers in Drug Development for Antiretroviral Therapies, was held on 9-12 December 2008 in Puerto Rico. The stated purpose of this biannual international meeting is to assemble clinicians, researchers and basic scientists together to advance the knowledge of the ongoing drug development processes in antiretroviral research. However, there were also presentations of thematic reviews of clinical topics such as prevention and drug resistance; HIV therapy in developing countries; and HIV/hepatitis and other coinfections. This report focuses on the main theme of the conference, the antiretroviral drug development pipeline. The author is solely responsible for the selection of topics and presentations to be included in this report.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
HIV DART 2008, Frontiers in Drug Development for Antiretroviral Therapies, was held on 9-12 December 2008 in Puerto Rico. The stated purpose of this biannual international meeting is to assemble clinicians, researchers and basic scientists together to advance the knowledge of the ongoing drug development processes in antiretroviral research. However, there were also presentations of thematic reviews of clinical topics such as prevention and drug resistance; HIV therapy in developing countries; and HIV/hepatitis and other coinfections. This report focuses on the main theme of the conference, the antiretroviral drug development pipeline. The author is solely responsible for the selection of topics and presentations to be included in this report.
Key concepts: Antiretroviral drug, Human immunodeficiency virus (HIV), Antiretroviral therapy, Medicine, Drug development, ANTIRETROVIRAL AGENTS, Drug, Family medicine